About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Cardiorenal Protective Diet | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04117204

Cardiorenal Protective Diet

This study will evaluate providing fruits and vegetables in a sustainable community care clinic setting, in addition to routine medical care, to individuals with CKD (Stage 2-4) on CKD and CVD risk, o...

Lead sponsor: Baylor Research Institute•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Baylor Research Institute

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Willingness to participate in a 3-month F\&V study.
•Positive urine dipstick (Proteinuria and/or Albumin-to-Creatinine Ratio \>=10).
•African-American (self-declared) race
•A current diagnosis of hypertension or a current blood pressure reading consistent with hypertension (SBP \>= 140 and/or DBP \>=90).
•Access to the internet via personal computer or mobile device.
•Ability to read and write in English.

Exclusion Criteria

•Negative urine dipstick.
•Currently receiving dialysis or needing dialysis (Stage 5 Kidney Disease)
•Have received or need a kidney transplant.
•Pregnant or planning to become pregnant in the next 6 months.
•Baseline urine potassium \> 60mEq/g creatinine
•Negative diagnosis of hypertension or blood pressure reading (SBP \<140 or DBP \<90).
•Nephrotic proteinuria demonstrated on urine ACR measurement.
•Lacking access to the internet via personal computer or mobile device.
•Unable to read or write in English.

Related studies

RECRUITINGPhase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT07218029 · Pulmonary Arterial Hypertension

RECRUITINGPhase 3

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

NCT07365332 · Pulmonary Arterial Hypertension

Natural History of Noncirrhotic Portal Hypertension

NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more

RECRUITINGPhase 1/2

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 29, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment101

Start dateJun 2019

Last updatedJan 29, 2021

Condition

Chronic Kidney Diseases Cardiovascular Diseases Hypertension

Locations shown

Baylor Scott & White Health and Wellness Center

Dallas, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions